GLOBAL IDURONATE 2 SULFATASE MARKET 2018 BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2023

Nov 2018 123

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) pipeline Target constitutes close to 11 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes.

Scope of the Report:

Iduronate 2-sulfatase (IDS) is a sulfatase enzyme associated with Hunter syndrome. Iduronate 2-sulfatase is required for the lysosomal degradation of heparan sulfate and dermatan sulfate. Mutations in this X-chromosome gene that result in enzymatic deficiency lead to Hunter syndrome.

The global Iduronate 2 Sulfatase market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Iduronate 2 Sulfatase.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Iduronate 2 Sulfatase market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Iduronate 2 Sulfatase market by product type and applications/end industries.

Market Segment by Companies, this report covers
- AngioChem
- ArmaGen
- Bioasis Technologies
- Green Cross
- JCR Pharmaceuticals
- Esteve
- RegenxBio
- Sangamo BioSciences
- Shire

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Alpha L Iduronate Sulfate Sulfatase
- Idursulfase
- IDS
- EC 3.1.6.13

Market Segment by Applications, can be divided into
- Hospitals
- Ambulatory Surgical Centers
- Others

Table of Contents

Related reports :

(Dec 19)

Description Scope of the Report: The worldwide market for Point-of-Care or Rapid Diagnostics Device is expected to gro...

(Dec 19)

Description Scope of the Report: The worldwide market for Point-of-Care or Rapid Testing Kit is expected to grow at a ...

(Dec 19)

Description Scope of the Report: The worldwide market for Point-of-Care or Rapid Testing is expected to grow at a CAGR...

(Dec 19)

Description Scope of the Report: The worldwide market for Point-of-Care or Rapid Diagnostics is expected to grow at a ...

(Dec 19)

Description Scope of the Report: The global Cystatin C Testing market is valued at xx million USD in 2018 and is expec...

(Dec 19)

Description Scope of the Report: The worldwide market for Ureterorenoscope is expected to grow at a CAGR of roughly xx...

GLOBAL IDURONATE 2 SULFATASE MARKET 2018 BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2023

Global Info Research

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medical Devices market as per your needs. Get the best of Medical Devices research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy